These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 13780399)

  • 41. Influence of CaNa2 EDTA on topical 5-aminolaevulinic acid photodynamic therapy.
    Liu HF; Xu SZ; Zhang CR
    Chin Med J (Engl); 2004 Jun; 117(6):922-6. PubMed ID: 15198900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Is the prevention of lead poisoning with calcium edathamil possible?].
    POTT R
    Arch Gewerbepathol Gewerbehyg; 1959; 17():354-64. PubMed ID: 14434464
    [No Abstract]   [Full Text] [Related]  

  • 43. THE PROPHYLACTIC USE OF DISODIUM-CALCIUM VERSENATE IN EXPERIMENTAL LEAD POISONING IN RABBITS. II. EFFECT ON CATALASE ACTIVITY OF ERYTHROCYTES.
    SROCZYNSKI J; JONDERKO G
    Arch Immunol Ther Exp (Warsz); 1964; 12():229-31. PubMed ID: 14166663
    [No Abstract]   [Full Text] [Related]  

  • 44. THE PROPHYLACTIC USE OF DISODIUM-CALCIUM VERSENATE IN EXPERIMENTAL LEAD POISONING IN RABBITS. I. EFFECT ON THE BLOOD LEVELS OF REDUCED GLUTATHIONE.
    SROCZYNSKI J; JONDERKO G
    Arch Immunol Ther Exp (Warsz); 1964; 12():225-8. PubMed ID: 14166662
    [No Abstract]   [Full Text] [Related]  

  • 45. Fatal nephropathy during edathamil therapy in lead poisoning.
    BRUGSCH HG
    AMA Arch Ind Health; 1959 Oct; 20():285-92. PubMed ID: 13805211
    [No Abstract]   [Full Text] [Related]  

  • 46. Caries potentiating effect of Na EDTA, Ca EDTA, and Mg EDTA in the rat.
    ZIPKIN I; LARSON RH
    J Dent Res; 1959; 38():1240. PubMed ID: 13847619
    [No Abstract]   [Full Text] [Related]  

  • 47. The comparison of BAL (2, 3-dimercaptopropanol) and Ca EDTA (calcium ethylene diamine tetra acetate) in the treatment of lead encephalopathy.
    BRADLEY JE; BALDWIN RW; MENON G
    Bull Georgetown Univ Med Cent; 1957 Jan; 10(3):79-82. PubMed ID: 13404369
    [No Abstract]   [Full Text] [Related]  

  • 48. [Urinary and fecal elimination of lead and behavior of porphyrin in feces and urine in experimental chronic lead poisoning treated with edathamil calcium-disodium].
    ZAMBRANO A; MANGIERI A; SILVESTRONI A
    Boll Soc Ital Biol Sper; 1955 Jun; 31(6):611. PubMed ID: 13269539
    [No Abstract]   [Full Text] [Related]  

  • 49. New methods of deleading heavy lead absorption using calcium mono sodium ethylene diamine tetra acetate (EDTA).
    BELKNAP EL
    Henry Ford Hosp Med Bull; 1956 Dec; 4(4):210-3. PubMed ID: 13384915
    [No Abstract]   [Full Text] [Related]  

  • 50. [CLINICAL VALUES OF DELTA-AMINOLEVULINIC ACID IN LEAD POISONING].
    EFE S
    Turk Tip Cemiy Mecm; 1963 Oct; 29():584-92. PubMed ID: 14096260
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of lead poisoning by edathamil calcium-disodium.
    SHIELS DO; THOMAS DL; KEARLEY E
    AMA Arch Ind Health; 1956 May; 13(5):489-98. PubMed ID: 13312679
    [No Abstract]   [Full Text] [Related]  

  • 52. Misuse of edathamil calciumdisodium for prophylaxis of lead poisoning.
    KEHOE RA
    J Am Med Assoc; 1955 Jan; 157(4):341-2. PubMed ID: 13221424
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of ethylenediaminetetracetic acid and of vitamins B1 and B12 on the course of lead poisoning. (Experimental studies)].
    LIUBETSKII KhZ; SHRAIBER LB; KAZAKOV KS; ADAMIAN RI; ABRAMOVA LI
    Gig Tr Prof Zabol; 1962 Dec; 6():45-6. PubMed ID: 13931042
    [No Abstract]   [Full Text] [Related]  

  • 54. [Lead poisoning. Apropos of a case of acute encephalopathy in an adult].
    Dubi J; Schneider P; Regli F
    Schweiz Med Wochenschr; 1979 Jan; 109(4):123-7. PubMed ID: 219472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment by a chelator (calcium EDTA) of a case of occupational saturnine encephalopathy].
    SAMBRON J; GASTARD J
    Therapie; 1960; 15():353-60. PubMed ID: 14441205
    [No Abstract]   [Full Text] [Related]  

  • 56. [Aspects of the elimination of lead in saturnism during treatment with Versenate].
    PETTINATI L; GRIBAUDO C; COSCIA GC; SARACCO C
    Folia Med (Napoli); 1962 Feb; 45():89-104. PubMed ID: 14486040
    [No Abstract]   [Full Text] [Related]  

  • 57. [Magnesium metabolism in chronic lead poisoning: influence of chelating treatment].
    Hermann J; Lonchamp P; Duc M
    Magnesium; 1985; 4(5-6):312-5. PubMed ID: 3938831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of inorganic lead poisoning with edathamil calcium-disodium.
    BELKNAP EL; PERRY MC
    AMA Arch Ind Health; 1954 Dec; 10(6):530-47. PubMed ID: 13206449
    [No Abstract]   [Full Text] [Related]  

  • 59. [Cytogenetic action of versenate (Na2-Ca-EDTA) in subjects with normal and increased blood lead levels (author's transl)].
    Sarto F
    Med Lav; 1980; 71(2):141-8. PubMed ID: 6780774
    [No Abstract]   [Full Text] [Related]  

  • 60. [Dynamic study of the excretory function of the liver before and after combined therapy with calcium disodium ethylenediaminetetraacetate and adenosine triphosphoric acid].
    Ivanova S; Dicheva Ts
    Probl Khig; 1975; 1():107-10. PubMed ID: 829280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.